A metabolic dependency of EBV can be targeted to hinder B cell transformation.
Müller-Durovic B, Jäger J, Engelmann C, Schuhmachers P, Altermatt S, Schlup Y, Duthaler U, Makowiec C, Unterstab G, Roffeis S, Xhafa E, Assmann N, Trulsson F, Steiner R, Edwards-Hicks J, West J, Turner L, Develioglu L, Ivanek R, Azzi T, Dehio P, Berger C; Swiss Transplant Cohort Study#; Kuzmin D, Saboz S, Mautner J, Löliger J, Geigges M, Palianina D, Khanna N, Dirnhofer S, Münz C, Bantug GR, Hess C, Berger C, Hess C, Koller M, Rossi S, Stampf S, Müller NJ.
Müller-Durovic B, et al. Among authors: koller m.
Science. 2024 May 23:eadk4898. doi: 10.1126/science.adk4898. Online ahead of print.
Science. 2024.
PMID: 38781354